10176- IM-7 B7-H3-TARGETED CAR-T AND CAR-NK CELLS AGAINST HUMAN GLIOBLASTOMA
Tetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, Koki Murakami, Naoki Hosen, Haruhiko Kishima · 2024
Read 10176- IM-7 B7-H3-TARGETED CAR-T AND CAR-NK CELLS AGAINST HUMAN GLIOBLASTOMA by Tetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, Koki Murakami, Naoki Hosen, Haruhiko Kishima (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605555.txt.
Description
Tetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, Koki Murakami, Naoki Hosen, and Haruhiko Kishima test two engineered cell therapies against glioblastoma, the most lethal primary brain tumor. Both therapies give immune cells a chimeric antigen receptor aimed at B7-H3, a protein found heavily on these tumors. One version uses the patient's own T cells; the other uses natural killer cells from cord blood, which could be stored ready-made since they do not cause graft-versus-host disease.
The team built both cell types and tested them against tumor cells taken from patients. In dishes, both killed the cancer cells strongly. Injected into the brains of mice carrying patient-derived tumors, both slowed tumor growth markedly. The authors conclude that the ready-made killer-cell version deserves development alongside the personalized T-cell approach.
Catalog record
| CREATOR | Tetsuro Tachi, Noriyuki Kijima, Hideki Kuroda, Koki Murakami, Naoki Hosen, Haruhiko Kishima |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |